Clinical observations on infliximab treatment of infantile onset Takayasu arteritis

There is insufficient evidence on the clinical effectiveness and safety of infliximab (IFX) treatment of Takayasu arteritis (TA) in infants.

Source: Pediatric Rheumatology - August 4, 2022 Category: Rheumatology Authors: Min Kang, Jianming Lai, Dan Zhang, Yingjie Xu, Jia Zhu and Ming Li Tags: Research article Source Type: research